Hedge Fund Darling Mirati’s $5 Billion Stock Rally Set for Test

(Bloomberg) -- Mirati Therapeutics Inc. has more than doubled from March lows, amassing a market value of over $8 billion, though it has yet to produce a marketable drug.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.